| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 26, 2024 |
Director
Trans History: 85
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 240 | -- | 27,299 |
| Apr 26, 2024 |
Director
Trans History: 110
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 285 | -- | 27,346 |
| Apr 26, 2024 |
Director
Trans History: 624
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 163 | -- | 122,228 |
| Apr 26, 2024 |
Principal Accounting Officer
Trans History: 18
|
Principal Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65 | -- | 6,414 |
| Apr 26, 2024 |
EVP & General Counsel
Trans History: 234
|
EVP & General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 672 | -- | 95,589 |
| Apr 26, 2024 |
Chief of Staff
Trans History: 132
|
Chief of Staff | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 849 | -- | 103,575 |
| Apr 26, 2024 |
Director
Trans History: 24
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 89 | -- | 8,541 |
| Apr 15, 2024 |
Director
Trans History: 43
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 2,300 | $22.36 | 139,804 |
| Mar 28, 2024 |
EVP Chief Risk Officer
Trans History: 47
|
EVP Chief Risk Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 161 | $20.44 | 2,489 |
| Mar 28, 2024 |
Director, President & CEO
Trans History: 641
|
Director, President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 747 | $20.44 | 13,099 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.